Form 8-K - Current report:
SEC Accession No. 0001213900-25-030640
Filing Date
2025-04-10
Accepted
2025-04-10 16:01:22
Documents
15
Period of Report
2025-04-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0237224-8k_pmgchold.htm   iXBRL 8-K 42829
2 DEVELOPMENT AND LICENSE AGREEMENT BETWEEN NORTHSTRIVE BIOSCIENCES INC. AND YUVA ea023722401ex10-1_pmgchold.htm EX-10.1 133473
3 PRESS RELEASE DATED APRIL 10, 2025 ea023722401ex99-1_pmgchold.htm EX-99.1 14817
  Complete submission text file 0001213900-25-030640.txt   410248

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE elab-20250409.xsd EX-101.SCH 3026
5 XBRL LABEL FILE elab-20250409_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE elab-20250409_pre.xml EX-101.PRE 22366
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0237224-8k_pmgchold_htm.xml XML 3797
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25828284
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)